Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket

Author: Avi Kapoor | September 16, 2024 06:07am

Shares of Exicure, Inc. (NASDAQ:XCUR) rose sharply in today's pre-market trading after the company entered into debt-for-equity exchange agreements and regained Nasdaq compliance.

Exicure shares jumped 49.3% to $2.39 in the pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

NuCana plc (NASDAQ:NCNA) gained 94.4% to $4.94 in pre-market trading. NuCana presented final data from Phase 2 Nutide:701 study at ESMO Congress on NUC-7738 in combination with pembrolizumab for patients with metastatic melanoma who were refractory to or had relapsed on prior PD-1 inhibitor therapy.
Dermata Therapeutics, Inc.. (NASDAQ:DRMA) rose 73.4% to $2.74 in today's pre-market trading after gaining around 7% on Tuesday.
Agape ATP Corporation (NASDAQ:ATPC) gained 53.1% to $2.68 in the pre-market trading session. Agape ATP shares jumped over 20% on Friday after the company announced it entered into a strategic collaboration with Xiamen Photons Solar Technology that focusing on developing solar photovoltaic mounting systems in ASEAN countries.
Tenon Medical, Inc. (NASDAQ:TNON) gained 22.1% to $9.22 in pre-market trading after jumping around 72% on Friday. The company announced the pricing of a $4.5 million public offering of 1.22 million shares and warrants.
iTeos Therapeutics, Inc. (NASDAQ:ITOS) rose 20.1% to $20.05 in pre-market trading. iTeos Therapeutics announced follow-up interim data from GALAXIES Lung-201 Phase 2 platform study sponsored by GSK, for Belrestotug+Dostarlimab doublet in previously untreated, unresectable, locally advanced or metastatic PD-L1 high non-small cell lung cancer.
IO Biotech, Inc. (NASDAQ:IOBT) rose 18.2% to $0.8874 in pre-market trading. IO Biotech announced data from Phase 2 Basket trial of IO102-IO103, therapeutic cancer vaccine candidate, in combination with Merck’s Keytruda at the 2024 ESMO Congress.
Yunji Inc. (NASDAQ:YJ) gained 14.3% to $2.48 in pre-market trading after gaining 12% on Friday.
Adagene Inc. (NASDAQ:ADAG) shares rose 13.7% to $ 3.97 in pre-market trading. Adagene announced new ADG126 clinical data from ongoing Phase 1b/2 trial of SAFEbody Plus Keytruda Combo Presented at the ESMO Congress.
Entero Therapeutics, Inc. (NASDAQ:ENTO) gained 9% to $0.38 in pre-market trading after gaining around 6% on Friday.

Losers

Rafael Holdings, Inc. (NYSE:RFL) fell 40.1% to $1.00 in pre-market trading after gaining 9% on Friday.
SMX (Security Matters) Public Limited Company (NASDAQ:SMX) shares dipped 21.8% to $4.65 in pre-market trading after surging 143% on Friday.
Presidio Property Trust, Inc. (NASDAQ:SQFT) fell 20.4% to $0.55 in pre-market trading.
Psyence Biomedical Ltd. (NASDAQ:PBM) shares fell 16.7% to $0.13 in pre-market trading. Psyence Biomedical announced the receipt of staff delisting determination from Nasdaq.
Edgio, Inc. (NASDAQ:EGIO) shares declined 14.7% to $1.33 in pre-market trading after dipping 27% on Friday.
Universe Pharmaceuticals INC (NASDAQ:UPC) shares fell 11.6% to $0.48 in pre-market trading after dipping around 67% on Friday.
Protagenic Therapeutics, Inc. (NASDAQ:PTIX) shares fell 11.4% to $0.7001 in pre-market trading after declining 9% on Friday.
Purple Biotech Ltd (NASDAQ:PPBT) shares declined 11.2% to $0.3438 in pre-market trading after gaining 7% on Friday.
LeddarTech Holdings Inc. (NASDAQ:LDTC) fell 9.4% to $0.4001 in today's pre-market trading.
Guardant Health, Inc. (NASDAQ:GH) declined 8.2% to $24.60 in pre-market trading after gaining around 5% on Friday.